These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216 [Abstract] [Full Text] [Related]
3. Passively acquired anti-tetanus and anti-Haemophilus antibodies and the response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in infancy. Kurikka S, Olander RM, Eskola J, Käyhty H. Pediatr Infect Dis J; 1996 Jun 10; 15(6):530-5. PubMed ID: 8783351 [Abstract] [Full Text] [Related]
4. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ. Bull World Health Organ; 2000 Jun 10; 78(3):364-71. PubMed ID: 10812736 [Abstract] [Full Text] [Related]
6. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Schmitt HJ, Zepp F, Müschenborn S, Sümenicht G, Schuind A, Beutel K, Knuf M, Bock HL, Bogaerts H, Clemens R. Eur J Pediatr; 1998 Mar 10; 157(3):208-14. PubMed ID: 9537487 [Abstract] [Full Text] [Related]
9. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ. Southeast Asian J Trop Med Public Health; 1997 Mar 10; 28(1):91-8. PubMed ID: 9322290 [Abstract] [Full Text] [Related]
14. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Pediatrics; 1995 Apr 10; 95(4):522-7. PubMed ID: 7700752 [Abstract] [Full Text] [Related]
15. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D, Kakazo M, Saleu G, Taime J, Javati A, Namuigi P, Alpers MP, Wegmüller B, Zellmeyer M, Fürer E, Que JU, Herzog C. P N G Med J; 2001 Apr 10; 44(1-2):6-16. PubMed ID: 12418673 [Abstract] [Full Text] [Related]
16. Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Kurikka S, Käyhty H, Peltola H, Saarinen L, Eskola J, Mäkelä PH. Pediatrics; 1995 Jun 10; 95(6):815-22. PubMed ID: 7761204 [Abstract] [Full Text] [Related]
17. Immunogenicity of one, two or three doses of a meningococcal C conjugate vaccine conjugated to tetanus toxoid, given as a three-dose primary vaccination course in UK infants at 2, 3 and 4 months of age with acellular pertussis-containing DTP/Hib vaccine. Southern J, Crowley-Luke A, Borrow R, Andrews N, Miller E. Vaccine; 2006 Jan 12; 24(2):215-9. PubMed ID: 16112255 [Abstract] [Full Text] [Related]
18. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States. Marshall GS, Marchant CD, Blatter M, Friedland LR, Aris E, Miller JM. Hum Vaccin; 2011 Feb 12; 7(2):258-64. PubMed ID: 21307655 [Abstract] [Full Text] [Related]